Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate.

Stevenson MD, Jones ML.

Med Decis Making. 2011 Jan-Feb;31(1):43-52. doi: 10.1177/0272989X10364848. Epub 2010 Apr 7.

PMID:
20375420
[PubMed - indexed for MEDLINE]
2.

Vitamin K to prevent fractures in older women: systematic review and economic evaluation.

Stevenson M, Lloyd-Jones M, Papaioannou D.

Health Technol Assess. 2009 Sep;13(45):iii-xi, 1-134. doi: 10.3310/hta13450. Review.

PMID:
19818211
[PubMed - indexed for MEDLINE]
Free Article
3.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
[PubMed - indexed for MEDLINE]
4.

The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.

Stevenson M, Davis S, Lloyd-Jones M, Beverley C.

Health Technol Assess. 2007 Feb;11(4):1-134. Review.

PMID:
17280622
[PubMed - indexed for MEDLINE]
Free Article
5.

Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women.

Sawka AM, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L.

BMC Musculoskelet Disord. 2005 Jul 11;6:39. Review.

PMID:
16008835
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

Kanis JA, Stevenson M, McCloskey EV, Davis S, Lloyd-Jones M.

Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. Review.

PMID:
17311734
[PubMed - indexed for MEDLINE]
Free Article
7.

Bisphosphonates for prevention of postmenopausal osteoporosis.

Ravn P.

Dan Med Bull. 2002 Feb;49(1):1-18. Review.

PMID:
11894721
[PubMed - indexed for MEDLINE]
8.

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.

Boonen S, Laan RF, Barton IP, Watts NB.

Osteoporos Int. 2005 Oct;16(10):1291-8. Epub 2005 Jun 29. Review.

PMID:
15986101
[PubMed - indexed for MEDLINE]
9.

Long-term experience with alendronate in the treatment of osteoporosis.

Hochberg MC, Rizzoli R.

Expert Opin Pharmacother. 2006 Jun;7(9):1201-10. Review.

PMID:
16732706
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.

Hiligsmann M, Vanoverberghe M, Neuprez A, Bruyère O, Reginster JY.

Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):359-66. doi: 10.1586/erp.10.53. Review.

PMID:
20715911
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
[PubMed - indexed for MEDLINE]
12.

Alendronate for fracture prevention in postmenopause.

Holder KK, Kerley SS.

Am Fam Physician. 2008 Sep 1;78(5):579-81. Review.

PMID:
18788232
[PubMed - indexed for MEDLINE]
Free Article
13.

[Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].

Sato S.

Clin Calcium. 2007 Apr;17(4):600-5. Review. Japanese.

PMID:
17404491
[PubMed - indexed for MEDLINE]
14.

[Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].

Bartl R.

Dtsch Med Wochenschr. 2007 May 4;132(18):995-9. Review. German. No abstract available.

PMID:
17457784
[PubMed - indexed for MEDLINE]
15.

[Alendronate].

Okazaki R.

Clin Calcium. 2008 Oct;18(10):1410-6. doi: CliCa081014101416. Review. Japanese.

PMID:
18830037
[PubMed - indexed for MEDLINE]
16.

Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.

Lufkin EG, Sarkar S, Kulkarni PM, Ciaccia AV, Siddhanti S, Stock J, Plouffe L Jr.

Curr Med Res Opin. 2004 Mar;20(3):351-7. Review.

PMID:
15025844
[PubMed - indexed for MEDLINE]
17.

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.

Osteoporos Int. 2006 Feb;17(2):273-80. Epub 2005 Sep 2. Review.

PMID:
16142502
[PubMed - indexed for MEDLINE]
18.

Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.

Pyon EY.

Clin Ther. 2006 Apr;28(4):475-90. Review.

PMID:
16750461
[PubMed - indexed for MEDLINE]
19.

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

Reginster JY.

Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Review.

PMID:
21175240
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk